HOME >> BIOLOGY >> NEWS
3.2 billion-year-old surprise: Earth had strong magnetic field

ot be good enough. The technique was developed more than four decades ago, and has changed little. With the old method, an igneous rock about an inch across is heated and cooled in a chamber that is shielded from magnetic interference. The magnetism is essentially drained from the particles in the rock and then its refilled while scientists measure how much the particles can hold.

Tarduno, however, isolates choice, individual crystals from a rock, heats them with a laser, and measures their magnetic intensity with a super-sensitive detector called a SQUIDa Superconducting Quantum Interface Device normally used in computing chip design because its extremely sensitive to the tiniest magnetic fields.

Certain rocks contain tiny crystals like feldspar and quartznano-meter sized magnetic inclusions that lock in a record of the Earths magnetic field as they cool from molten magma to hard rock. Simply finding rocks of this age is difficult enough, but these rocks have also witnessed billions of years of geological activity that could have reheated them and possibly changed their initial magnetic record. To reduce the chance of this contamination, Tarduno picked out the best preserved grains of feldspar and quartz out of 3.2 billion-year-old granite outcroppings in South Africa. Feldspar and quartz are good preservers of the paleomagnetic record because their minute magnetic inclusions essentially take a snapshot of the field as they cool from a molten state. Tarduno wanted to measure the smallest magnetic inclusions because larger magnetic crystals can lose their original magnetic signature at much lower temperatures, meaning they are more likely to suffer magnetic contamination from later warming geological events.

Once he isolated the ideal crystals, Tarduno employed a carbon dioxide laser to heat individual crystals much more quickly than older methods, further lessening the chance of contamination. With the Universitys ultra-sensitive SQUID he could me
'"/>

Contact: Jonathan Sherwood
jonathan.sherwood@rochester.edu
585-273-4726
University of Rochester
4-Apr-2007


Page: 1 2 3

Related biology news :

1. What we can learn from the biggest extinction in the history of Earth
2. Chickens also orient themselves by the Earths magnetic field
3. Scientists ponder plant life on extrasolar Earthlike planets
4. NASA-funded robotic sub makes final dive to reach bottom of Earths deepest sinkhole
5. ESA presents the sharpest ever satellite map of Earth
6. Prototype space probe prepares to explore Earths deepest sinkhole
7. Worlds oldest rocks show how Earth may have dodged frozen fate of Mars
8. Climate change only one symptom of a stressed planet Earth
9. Researchers identify a heartbeat in Earths climate
10. Symposium Changes on Earth honors Yale Geologist Robert Berner
11. The Milky Way shaped life on Earth

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: billion year old surprise Earth had strong magnetic field

(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
(Date:4/16/2015)... (PRWEB) April 16, 2015 Regis Technologies ... American Association for Cancer Research (AACR) annual meeting. Regis ... Convention Center, starting Saturday, April 18, in Philadelphia and ... claim to title of the oldest and largest organization ... fellowships and grants, and partners with survivors to promote ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
(Date:4/16/2015)... 16, 2015  In recognition of World Hemophilia Day, ... groups to illuminate more than 15 prominent landmarks red throughout ... Boston,s Zakim Bridge and Prudential Tower, ... Mercedes-Benz Superdome and Denver,s ... of April 17, and coincide with hemophilia community events in ...
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
Breaking Biology Technology:Regis Technologies Joins American Association for Cancer Research Annual Meeting 2OncoTAb Names Dr. David L. Cooper as COO 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
Cached News: